Skip to content
The Policy VaultThe Policy Vault

Tasigna — Medica

Chronic myeloid leukemia (Philadelphia chromosome-positive or BCR::ABL1 mutation positive)

Initial criteria

  • Patient has Philadelphia chromosome-positive chronic myeloid leukemia OR patient has BCR::ABL1-mutation positive chronic myeloid leukemia

Approval duration

1 year